Literature DB >> 29698294

Letter to the Editor: Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Ling-Ling Sun1, Shi-Hong Ren, Bing-Hao Li, Heng-Yuan Li, Xin Huang, Zhao-Ming Ye.   

Abstract

Mesh:

Year:  2018        PMID: 29698294      PMCID: PMC6263584          DOI: 10.1097/01.blo.0000533633.61839.23

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

1.  Impact severity of local recurrence in giant cell tumor of bone.

Authors:  Richard L McGough; Janie Rutledge; Valerae O Lewis; Patrick P Lin; Alan W Yasko
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

2.  En Bloc Resection Versus Intralesional Surgery in the Treatment of Giant Cell Tumor of the Spine.

Authors:  Raphaële Charest-Morin; Charles G Fisher; Peter P Varga; Ziya L Gokaslan; Laurence D Rhines; Jeremy J Reynolds; Mark B Dekutoski; Nasir A Quraishi; Mark H Bilsky; Michael G Fehlings; Dean Chou; Niccole M Germscheid; Alessandro Luzzati; Stefano Boriani
Journal:  Spine (Phila Pa 1976)       Date:  2017-09-15       Impact factor: 3.468

3.  Giant cell tumor of bone: risk factors for recurrence.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-08-13       Impact factor: 4.176

4.  Immune Surveillance Plays a Role in Locally Aggressive Giant Cell Lesions of Bone.

Authors:  Ahmad Al-Sukaini; Francis J Hornicek; Zachary S Peacock; Leonard B Kaban; Soldano Ferrone; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2017-07-19       Impact factor: 4.176

5.  Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy.

Authors:  Wolfgang T Becker; Jörn Dohle; Ludger Bernd; Arnim Braun; Miklos Cserhati; Alfred Enderle; Louis Hovy; Zdenek Matejovsky; Miklos Szendroi; Klemens Trieb; Per-Ulf Tunn
Journal:  J Bone Joint Surg Am       Date:  2008-05       Impact factor: 5.284

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.